Clopidogrel resistance in stroke patients (The CRISP Trial)
نویسندگان
چکیده
منابع مشابه
Evaluation of clopidogrel resistance in ischemic stroke patients.
OBJECTIVE Clopidogrel has potent antiplatelet effects, but recent interest has focused on clopidogrel resistance, in which platelet function is not inhibited despite taking the drug. This study evaluated clopidogrel resistance in ischemic stroke patients. METHODS After taking oral clopidogrel 75 mg/day for ≥1 week, platelet aggregometry was performed by turbidimetry in all patients, and by a ...
متن کاملClopidogrel and Its Use in Stroke Patients
Clopidogrel and Its Use in Stroke Patients To the Editor: Substantial clinical data support the use of antiplatelet therapy in reducing the incidence of secondary atherothrombotic events in individuals who have experienced a transient ischemic attack (TIA) or stroke.1 The consensus based on recent trials is that antiplatelet therapy can reduce the incidence of subsequent ischemic events in thos...
متن کاملClopidogrel and its use in stroke patients.
Clopidogrel and Its Use in Stroke Patients To the Editor: Substantial clinical data support the use of antiplatelet therapy in reducing the incidence of secondary atherothrombotic events in individuals who have experienced a transient ischemic attack (TIA) or stroke.1 The consensus based on recent trials is that antiplatelet therapy can reduce the incidence of subsequent ischemic events in thos...
متن کاملResistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention
To study the resistance to standard dosage of clopidogrel among Iranian patients following percutaneous coronary intervention measured by platelet aggregation test.Patients undergoing percutaneous coronary intervention in Imam Hussein Medical center, Tehran, Iran, who were under treatment with aspirin, but had no history of clopidogrel usage, entered the study. Patients received standard dosage...
متن کاملResistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention
To study the resistance to standard dosage of clopidogrel among Iranian patients following percutaneous coronary intervention measured by platelet aggregation test.Patients undergoing percutaneous coronary intervention in Imam Hussein Medical center, Tehran, Iran, who were under treatment with aspirin, but had no history of clopidogrel usage, entered the study. Patients received standard dosage...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurology & Stroke
سال: 2021
ISSN: 2373-6410
DOI: 10.15406/jnsk.2021.11.00444